SCHEMBL30116330

SCHEMBL30116330

CN(C)c1cccc2cccc(S(=O)(=O)Cl)c12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.59
▸ MAPT P10636 2/20 0.59
▸ KDM4E B2RXH2 1/20 0.59
▸ CA2 P00918 2/20 0.45
▸ HTR6 P50406 1/20 0.43
▸ F2 P00734 3/20 0.42
▸ PRSS1 P07477 3/20 0.42
▸ PRSS2 P07478 3/20 0.42
▸ PRSS3 P35030 3/20 0.42
▸ TDP1 Q9NUW8 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ EDNRA P25101 7/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9676821 1.00 GAA (0.59) GAAMAPTKDM4ECA2HTR6
SCHEMBL14845761 0.84 GAA (0.61) GAAMAPTKDM4ECA2HTR6
SCHEMBL8149846 0.84 CA2 (0.64) GAAMAPTKDM4ECA2HTR6
SCHEMBL4889389 0.82 GAA (0.59) GAAMAPTKDM4ECA2HTR6
SCHEMBL17322787 0.82 GAA (0.59) GAAMAPTKDM4ECA2HTR6
SCHEMBL15631840 0.81 GAA (0.57) GAAMAPTKDM4ECA2HTR6
SCHEMBL10048751 0.81 GAA (0.57) GAAMAPTKDM4ECA2HTR6
SCHEMBL14142748 0.79 GAA (0.55) GAAMAPTKDM4ECA2HTR6
SCHEMBL15075265 0.79 GAA (0.55) GAAMAPTKDM4ECA2HTR6
SCHEMBL13677633 0.79 MAPT (0.55) GAAMAPTKDM4ECA2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023278826-A2 METHODS FOR SELECTING LUNG CANCER PATIENTS FOR TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2023-01-05 — — WO disclosed
Send feedback